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Gene expression profiling of neurochemically defined regions of
the human brain by in situ hybridization-guided laser capture
microdissection
Abstract
Laser capture microdissection (LCM) permits isolation of specific cell types and cell groups based upon
morphology, anatomical landmarks and histochemical properties. This powerful technique can be used
for region-specific dissection if the target structure is clearly delineated. However, it is difficult to
visualize anatomical boundaries in an unstained specimen, while histological staining can complicate
the microdissection process and compromise downstream processing and analysis. We now introduce a
novel method in which in situ hybridization (ISH) signal is used to guide LCM on adjacent unstained
sections to collect tissue from neurochemically defined regions of the human postmortem brain to
minimize sample manipulation prior to analysis. This approach was validated in nuclei that provide
monoaminergic inputs to the forebrain, and likely contribute to the pathophysiology of mood disorders.
This method was used successfully to carry out gene expression profiling and quantitative real-time
PCR (qPCR) confirmation from the dissected material. When compared to traditional micropunch
dissections, our ISH-guided LCM method provided enhanced signal intensity for mRNAs of specific
monoaminergic marker genes as measured by genome-wide gene expression microarrays. Enriched
expression of specific monoaminergic genes (as determined by microarrays and qPCR) was detected
within appropriate anatomical locations validating the accuracy of microdissection. Together these
results support the conclusion that ISH-guided LCM permits acquisition of enriched nucleus-specific
RNA that can be successfully used for downstream gene expression investigations. Future studies will
utilize this approach for gene expression profiling of neurochemically defined regions of postmortem
brains collected from mood disorder patients.
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Abstract
Laser capture microdissection (LCM) permits isolation of specific cell types and cell groups based
upon morphology, anatomical landmarks and histochemical properties. This powerful technique can
be used for region-specific dissection if the target structure is clearly delineated. However, it is
difficult to visualize anatomical boundaries in an unstained specimen, while histological staining can
complicate the microdissection process and compromise downstream processing and analysis. We
now introduce a novel method in which in situ hybridization (ISH) signal is used to guide LCM on
adjacent unstained sections to collect tissue from neurochemically-defined regions of the human
postmortem brain to minimize sample manipulation prior to analysis. This approach was validated
in nuclei that provide monoaminergic inputs to the forebrain, and likely contribute to the
pathophysiology of mood disorders. This method was used successfully to carry out gene expression
profiling and quantitative real-time PCR (qPCR) confirmation from the dissected material. When
compared to traditional micropunch dissections, our ISH-guided LCM method provided enhanced
signal intensity for mRNAs of specific monoaminergic marker genes as measured by genome-wide
gene expression microarrays. Enriched expression of specific monoaminergic genes (as determined
by microarrays and qPCR) was detected within appropriate anatomical locations validating the
accuracy of microdissection. Together these results support the conclusion that ISH-guided LCM
permits acquisition of enriched nucleus-specific RNA that can be successfully used for downstream
gene expression investigations. Future studies will utilize this approach for gene expression profiling
of neurochemically-defined regions of postmortem brains collected from mood disorder patients.
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Introduction
Microarray-based gene expression profiling studies have been successfully conducted in the
human brain (Mirnics et al., 2001; Baranzini, 2004). Such studies require extracted RNA from
dissected brain tissue, and two dissection approaches have been used: 1) gross dissection of
anatomically defined brain regions, and 2) laser capture microdissection (LCM) of specific
cell populations. While gross dissection assumes homogeneity within anatomically defined
brain regions, transcriptional expression may vary greatly within a certain brain structure, as
it consists of various cell types, neurons of different neurochemical phenotypes, as well as
those with different projection targets and afferent inputs. LCM has the advantage of allowing
precise acquisition of discrete populations of cells from histological brain samples, such as an
individual nucleus (Bonaventure et al., 2002). To define areas to be used for LCM, a variety
of histochemical stains have been used (Torres-Munoz et al., 2004; Greene et al., 2005).
However, such staining procedures increase complexity of the tissue processing protocol and
can negatively impact the outcome of downstream gene expression studies (Kerman et al.,
2006)
To circumvent this problem we have developed a simple method that minimizes processing of
tissue sections used for LCM. It utilizes in situ hybridization (ISH) and histological staining
on adjacent sections for visualization of: 1) major anatomical landmarks, and 2)
neurochemically-defined cell populations that define regions of interest. We validated this
approach in the postmortem human brain in areas that contain serotonergic (dorsal [DR] and
median [MR] raphe) and noradrenergic (locus coeruleus [LC]) neurons. These areas were
chosen because they: 1) are relatively small and circumscribed and are well-suited for LCM;
2) are adjacent to each other and allow us to directly evaluate the anatomical resolution of our
dissections; and 3) likely play a prominent role in the pathophysiology of neuropsychiatric
disorders. Our data demonstrate that this method can be effectively applied for anatomically
accurate microdissections, and then combined with downstream microarray and quantitative
real-time PCR (qPCR) gene expression measures.
Methods
Subjects
Acquisition of postmortem human brain samples, tissue processing, and procedures for
microarray experiments have been previously described (Evans et al., 2003; Evans et al.,
2004; Li et al., 2004; Tomita et al., 2004; Choudary et al., 2005). Ten subjects without known
psychiatric diagnoses were chosen for ISH-guided LCM (Table 1).
Tissue processing and ISH-guided LCM
Brainstem blocks were cryostat-sectioned (-20°C) in the coronal plane at 10 μm and stored at
-80°C. Pairs of adjacent sections 500 μm apart were then processed for radioactive ISHs to
detect serotonin (SERT; NM_001045.2; pos.705-1789) and norepinephrine (NET;
NM_001043; pos.1-1974) transporter mRNAs as previously published (Neal et al., 2001;
Lopez-Figueroa et al., 2004). SERT and NET ISH signals were used to define the boundaries
of DR, MR, and LC (Fig. 1). Specificity of labeling was confirmed by absence of signal utilizing
sense riboprobes (data not shown).
Following 72-hour exposure to radiosensitive film, the same tissue sections were stained with
luxol fast blue combined with cresyl violet. Slide sets from all subjects were then aligned to
match along the anterior-posterior axis using anatomical landmarks from the histochemically
stained slides and ISH signals.
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LCM was performed on unstained sections adjacent to those processed for ISH and
histochemical staining. For raphe studies we identified a common region 1.5 mm in length at
the mid-caudal level of the SERT signal in all subjects (∼ +25 to +27 mm from obex (Paxinos
and Huang, 1995)). We collected a total of 9 slides (1 section/slide) from 3 equally-spaced
levels (levels 500 μm apart, 3 adjacent slides/level). For LC studies, we collected a total of 4
slides, 500 μm apart from within a 2 mm common region of the mid-rostral portion of the
nucleus (∼ +25 to +27 mm from obex; (Paxinos and Huang, 1995)). For each subject a total
of 9 DR nuclei, 9 MR nuclei and 8 LC nuclei (bilateral collection) were collected. Slides were
thawed and dehydrated prior to LCM as previously described (Kerman et al., 2006).
LCM was performed with an AutoPix instrument (Molecular Devices, Sunnyvale, CA); laser
settings ranged from 50-75mW (power), 1,500-3,500 ms (duration) and 200-250 mV
(intensity). Position of anatomical landmarks (e.g. the fourth ventricle and medial longitudinal
fasciculus) from histochemically-stained images, and SERT or NET ISH signals were visually
projected onto sections used for LCM. Regions in unstained sections that corresponded to
boundaries of DR, MR, and LC were then microdissected under a 4x objective using CapSure
macrocaps (Molecular Devices) (Fig.1). Each cap contained 3 MR, 3 DR, or 4 LC
microdissected areas.
Micropunches
In order to compare data generated by ISH-guided LCM with an established microdissection
method using the micropunch technique, brainstem blocks from 2 additional subjects (both 79
years old, male, and Caucasian; 5.5 and 15 hrs. post-mortem intervals [PMI]) were collected
and yielded two samples from LC and one each from DR and MR. Brainstem blocks of these
subjects were coronally sectioned on a cryostat (at -20°C) to a thickness of 250 μm and then
stored at -80°C until further processing. Immediately prior to the dissections, sections were
warmed up to -25°C for 30 min and then placed on a TCP-2 thermoelectric cold plate
(Thermoelectrics Unlimited, Wilmington, DE). After quick visual inspection, regions of
interest (LC, DR and MR) were dissected using a micropuncher tool (3 mm diameter).
Dissected tissue from 4 sections were combined for each of the three nuclei and stored on dry
ice. RNA was extracted using RNAqueous isolation kit (Applied Biosystems, Foster City, CA),
quantified with Quant-iT™ PicoGreen dsDNA kit (Invitrogen, Carlsbad, CA) according to
manufacturer’s instructions, and then processed for hybridization to gene expression
microarrays as described below. Obtained data were compared to all samples from their
respective regions collected using ISH-guided LCM.
RNA isolation and amplification
In LCM samples RNA extraction and isolation were performed using the PicoPure RNA
Isolation kit (Molecular Devices) according to manufacturer’s instructions including DNase
treatment. For each nucleus, RNA extracts from the same subjects (3 caps for raphe nuclei and
2 for LC) were combined before purification. RNA quality was evaluated on a 2100
BioAnalyzer (Agilent Technologies, Palo Alto, CA), and different regions of resultant RNA
electropherograms were quantified according to the method of Schoor et al. (Schoor et al.,
2003)
RNA samples were then subjected to two rounds of amplification (RiboAmp OA RNA kit,
Molecular Devices) and subsequent biotin labeling (Perkin Elmer, Waltham, MA). After the
first round of amplification a portion of amplified double-stranded cDNA was saved for qPCR
(see Methods below). Following two amplification rounds, 15 μg of biotinylated aRNA from
each nucleus was then hybridized to HG-U133 Plus 2.0 arrays (Affymetrix, Santa Clara, CA)
per manufacturer’s instructions. Biotinylated RNA obtained from micropunched tissue was
hybridized to HG-U133A arrays (Affymetrix).
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Microarray data analysis
Affymetrix CEL files were analyzed using Robust Multi-Chip Average (RMA) and Affymetrix
Microarray Suite 5 (MAS5) calls algorithm. Affymetrix chip description files were replaced
by custom probe set mapping files
(
http://brainarray.mbni.med.umich.edu/Brainarray/Database/CustomCDF/genomic_curated_CDF.asp
) that independently reassigned all Affymetrix probe sets to an updated UniGene cluster (Build
No. 199). RMA output files containing log2-transformed intensity values for gene transcripts
were statistically analyzed using Prism 3.0 software (GraphPad, San Diego, CA). Genes were
considered for further analysis only if detected in ≥ 50% of all subjects according to
MAS5CALLS algorithm.
Based on low microarray percent present call rates (> 2*SD away from the mean) the following
subjects were excluded: subject 3706 (DR analysis), subject 3433 (LC analysis), subject 3416
(DR and MR analysis).
For gene expression comparison between LCM-dissected and micropunched nuclei, only probe
sets for genes present on both array types (HG-U133 Plus 2.0 and HG-U133A) were
considered. Due to the small sample size, genes were considered for analysis if detected by
MAS5CALLS algorithm.
Additionally, we mined our LCM microarray data for the expression of nonmonoaminergic
genes uniquely expressed in LC, DR, or MR. Criteria for uniquely enriched genes in one or
two of the three nuclei were: detection in at least 66% of subjects according to MAS5CALLS
and a log2 microarray intensity of 5.5. Genes with a MAS5CALLS rate between 66 and 33%
were not considered for nucleus-enrichment analysis.
Quantitative Real-Time PCR (qPCR)
QPCR employing SYBR Green chemistry was used to confirm microarray results.
Amplification reactions and fluorescence quantification were performed in real time using a
Bio-Rad iCycler (BioRad, Hercules, CA) in combination with a SYBR-488 detection protocol
using a touchdown PCR approach (Kerman et al., 2006). Amplification reactions were carried
out in 96 well PCR plates (Bio-Rad). Each well contained 5 μl of amplified double-stranded
cDNA (aDNA; 50 pg/μl) that was set aside following the first round RNA amplification. Prior
to amplification concentration of aDNA was quantified for each sample using Quant-iT
PicoGreen dsDNA kit (Invitrogen, Carlsbad, CA) according to manufacturer’s instructions.
Each qPCR well also contained 5 μl of forward and reverse strand primers (final concentration:
500 nM) and 10 μl of iQ SYBR Green Supermix (Bio-Rad).
All samples were run in triplicate and an average cycle threshold (Ct) was calculated for each
sample. Replicates that were ≥ 1 Ct away from the mean Ct were excluded; the mean Ct
included only the remaining duplicates. Subjects that produced only one Ct value were
excluded from further analysis. Since input amount of aDNA was equivalent across all samples,
raw Ct values were inversely proportional to the levels of gene expression. We chose this
approach rather than normalization to housekeeping genes because of the potential for
differential expression of such reference transcripts (Dheda et al., 2005; Wong and Medrano,
2005). A similar approach in which standardized DNA input amounts for qPCR were used has
recently been validated (Libus and Storchova, 2006).
Relative fold changes were calculated according to the following formula: 2-(Cta — Ctb) in which
Cta is cycle threshold in a region of interest and Ctb is cycle threshold in a reference region.
Following amplification, specificity of each reaction was confirmed by the presence of a single
peak on the melting curve, plotted as the negative derivative of fluorescence during incremental
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increases in well temperature. No template controls, in which aDNA was replaced with distilled
H2O, did not yield amplification products.
Primer Design
Genomic DNA and mRNA sequences were downloaded from NCBI LocusLink at
http://www.ncbi.nlm.nih.gov/LocusLink/ for: DDC, COMT, MAOA, MAOB, SERT, TPH2,
and VMAT2. PCR primer pairs were designed to anneal within 500 bp of the 3′ end and to
generate a single amplicon between 75 and 150 bp in size using Primer3 software (Rozen and
Skaletsky, 2000). . For each amplicon predicted secondary structure was minimized using DNA
Mfold (Zuker, 2003) (http://www.bioinfo.rpi.edu/applications/mfold/). Primer sequences are
listed in Table 2. Their performance was validated via serial dilutions and amplification
efficiency testing using human genomic DNA or aDNA from human brainstem sections. DNA
concentration was quantified using PicoGreen dsDNA kit (Invitrogen, Carlsbad, CA)
according to manufacturer’s instructions.
Statistical Analysis
Differences in gene expression were quantified as fold changes calculated in relation to either
the mean intensity (for microarray data) or mean Ct (for qPCR data) of a reference group. In
most cases values obtained from LC samples were used for reference; for MAOA and TPH2
gene expression in LC was not examined and so DR values were used for reference. Values >
1 represent upregulation in expression, while those < 1 represent downregulation relative either
to LC or DR.
GraphPad Prism 3.0 software was used for Analysis of variance (ANOVA) comparison of
microarray intensity values and fold changes calculated based on microarray and qPCR data.
Significant (p < 0.05) main effects were followed up with Bonferroni’s multiple comparison
post-hoc tests; significance level was set at p < 0.05.
Linear regression analyses across nuclei between microarray intensities and qPCR Cts of
common monoaminergic genes were performed using GraphPad Prism 3.0 software.
Results
LCM Compared to Micropunches
Our initial gene expression studies focused on determining the utility of using LCM as
compared to the traditional micropunch method. Analysis of microarray data revealed
considerably higher present call rates and signal intensities for all three nuclei in the LCM-
obtained samples versus the micropunch samples (Table 3). Furthermore, average gene
expression intensities were 2.4- (LC), 3.7- (DR), and 2.2- (MR) fold higher in LCM-dissected
material as compared to micropunches.
Analysis of specific monoaminergic mRNAs revealed substantial enrichment in expression in
the LCM-obtained material (Table 4). In this analysis signal intensity values were normalized
to the average intensity of three housekeeping genes: ACTB, GAPD, PPIA, which are routinely
used as reference transcripts in gene expression studies (Eisenberg and Levanon, 2003;Kerman
et al., 2006). All of the genes exhibited a large increase in their signal intensities in the LC,
ranging from about 3- to almost 40- fold greater in the LCM material (Table 4). In the raphe
nuclei, the two receptor mRNAs that were examined (ADRA2A and HTR2A) were only
detected in the LCM tissue, while signal intensities of the other transcripts were 3- to over 50-
fold higher in the tissue obtained from LCM dissection than from micropunches (Table 4).
Taken together these data indicate increased sensitivity of the LCM method as compared to
the micropunch collected samples. They also suggest greater dynamic range using this
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methodology that may facilitate detection of smaller differences in expression of rare
transcripts. Having demonstrated its improved performance as compared to the micropunch
method, we applied ISH-guided LCM to examine gene expression differences among specific
brainstem nuclei with defined neurochemical properties and known gene expression
differences.
RNA Quality
Initial assessment of RNA quality was performed using the Agilent BioAnalyzer instrument,
and visual inspection of the BioAnalyzer electropherograms revealed clear 28S and 18S peaks
(Fig. 2). To determine whether extracted RNA was of acceptable quality for downstream gene
expression analyses, we quantified different regions of each electropherogram according to the
method of Schoor, et al. (Schoor et al., 2003). These authors compared results of microarray-
and qPCR- based gene expression studies in samples with various levels of RNA degradation
and demonstrated that valid results can be obtained if electropherograms from input RNA
contain: 1) less than 65% of their signal in the pre-18S peak of the trace, and 2) more than 4%
of the signal in the 28S peak region (Schoor et al., 2003). Such analysis of our samples revealed
that the pre-18S peak region contained: 44.3 ± 2.4% (DR), 45.3 ± 2.6% (MR), and 47.4 ± 4.0%
(LC) of total signal, while the 28S peak region contained: 10.0 ± 1.7% (DR), 9.4 ± 0.9% (MR),
and 10.8 ± 0.9% (LC) of total signal. For technical reasons we were not able to quantify these
parameters in 3 of the samples. However, downstream gene expression measures (e.g.
microarray intensity values, microarray present call rates and qPCR Cts) were not different in
these samples. Taken together these data indicate that RNA extracted from our samples was
suitable for valid microarray- and qPCR- based gene expression studies.
ISH-Guided LCM
We then set out to determine the anatomic precision of ISH-guided LCM by examining
expression of genes known to be differentially enriched within the sampled brain regions. This
analysis revealed differential expression of such mRNAs across the three nuclei, with tyrosine
hydroxylase (TH), dopamine β-hydroxylase (DBH), and NET mRNA detected only in LC (Fig.
3). Conversely, expression of tryptophan hydroxylase 2 (TPH2), SERT, and monoamine
oxidase B (MAO-B) mRNA was greatly enriched within DR and MR. Expression of aromatic
amino acid decarboxylase (DDC), catechol-o-methyl transferase (COMT), monoamine
oxidase A (MAO-A), and vesicular monoamine transporter 2 (VMAT2) mRNA was detected
in all three regions. However, expression of phenylethanolamine N-methyltransferase (PNMT)
mRNA, an adrenergic marker, was not detected in any of the three nuclei.
QPCR analyses confirmed microarray findings as regional differences in gene expression were
consistently replicated by both methods (Fig. 4). Interestingly, changes in expression as
detected by microarrays and qPCR were in agreement in terms of direction of change (i.e.
upregulation vs. downregulation across nuclei), but were consistently greater in magnitude as
detected by qPCR (note the differences in the scale of y-axes in Fig. 4). In addition, we found
significant negative correlations between microarray intensity values and qPCR Cts (Fig. 5).
As expected increased microarray intensity values (indicating increased gene expression)
correlated with smaller Ct values (Fig. 5), further validating our gene expression findings.
To determine whether ISH guided-LCM method may also be used to identify novel non-
monoaminergic genes that are expressed in the three regions included in our study we mined
our data for such mRNAs. Results of this analysis are presented in Table 5. A number of genes
that are uniquely expressed in these nuclei were identified. Consistent with our findings,
previous studies in rodents have also documented enrichment of RGS3 and RGS4 expression
in the LC (Gold et al., 1997) and that of VIP in the raphe nuclei (Hill et al., 1994;Hill et al.,
2003).
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Discussion
The present study introduces a method for using ISH to guide LCM of neurochemically-defined
regions of the postmortem human brain for subsequent gene expression profiling by
microarrays and confirmation by qPCR. We demonstrate that ISH-guided LCM leads to
increased detection of specific mRNAs and to increased sensitivity in subsequent microarray
studies when compared to samples harvested with the micropunch technique from the same
nuclei. ISH-guided LCM was anatomically precise as evidenced by the patterns of expression
of genes known to be specifically expressed in the different brain regions examined in our
study. Regional differences in the expression of monoaminergic transcripts detected by
microarrays were confirmed by subsequent qPCR validation. In addition, we present
preliminary data suggesting that this approach may be used to identify novel transcripts
uniquely expressed in the regions of interest.
Micropunch dissection is a fast method to obtain macroscopically identified tissue that may be
used for gene expression profiling. It is relatively simple and can be used to microdissect
multiple specimens in a short period of time. In contrast, LCM is more labor-intensive, requires
additional reagents, tissue processing, and added expenses. We, therefore, set out to determine
whether an LCM approach may be advantageous. Our data indicate a substantial improvement
in the overall sensitivity and the dynamic range of microarray-based expression profiling of
LCM-collected samples as compared to those collected with micropunches. Despite limited
micropunch replicates that were used in this initial study, the results are compelling. Compared
to micropunches the LCM approach yields: 2.2-3.7- fold increase in overall gene expression,
nearly 50% increase in the number of detected transcripts, and as much as a 50-fold increase
in enrichment of mRNAs known to be selectively expressed in the regions included in this
study. We also observed that two of three housekeeping genes had higher microarray signal
intensities in micropunched tissue compared to LCM-obtained material (data not shown). This
finding suggests that overabundance of few non-specific genes in micropunched tissue masks
the signal for specific, monoaminergic genes. In addition, RNA integrity of micropunch and
LCM tissue was assessed as 3′ to 5′ signal intensities ratio of one internal control gene --
GAPDH. This analysis indicated comparable high RNA quality of micropunch and LCM
samples for all three nuclei (Supplemental Material, Table 1). Taken together our results
indicate that the limited anatomical resolution by micropunch dissections leads to decreased
detection of specific transcripts, whereas ISH-guided LCM enhances sample homogeneity as
reflected in increased sensitivity and enrichment of specific transcripts.
RNA quality is an important factor for subsequent gene expression profiling methods, as
severely degraded RNA can negatively impact outcomes of gene expression studies (Tomita
et al., 2004; Copois et al., 2007). Evaluation of postmortem RNA quality is not trivial, as
measures, such as 18S/28S ratio can be misleading since they quantify indicators of ribosomal
RNA to infer the quality of mRNA species, which are usually much smaller in size and may
be differentially susceptible to degradation (Schoor et al., 2003; Copois et al., 2007; Weis et
al., 2007). Studies utilizing postmortem tissues are faced with increased challenges mainly due
to the delay between death and brain collection that can negatively impact RNA integrity and
make it nearly impossible to obtain non-degraded RNA. Therefore, an important consideration
is whether such studies are compatible with gene expression studies, and whether partially
degraded input RNA can be used for valid gene expression analyses. To address this issue
Schoor and colleagues investigated effects of RNA degradation on gene expression as
measured by qPCR and microarrays. As a measure of RNA quality, they quantified total signal
within the different regions of BioAnalyzer electropherograms and concluded that RNA
samples are compatible with gene expression analyses if: 1) the region between marker and
18S peaks is less than 65% of the overall signal area, and 2) the 28S peak constitutes more than
4% of the overall signal (Schoor et al., 2003) . Using such cut-off criteria they demonstrated
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similar gene expression profiles between intact and partially degraded RNA samples (Schoor
et al., 2003) . Electropherograms from postmortem samples in our study show only a moderate
degree of degradation and fulfill the criteria for acceptable RNA quality (∼45% in pre-18S
region and ∼10% in 28S region) as defined by Schoor and colleagues.
One limitation of LCM is that increasingly complex tissue processing protocols that are often
required for tissue visualization can compromise downstream sample processing and
subsequent analyses (Kerman et al., 2006). To circumvent this problem, while still maintaining
the necessary anatomical precision of microdissection, we used: 1) images of ISH
autoradiograms from adjacent sections, and 2) images of adjacent sections stained with luxol
fast blue and cresyl violet to guide LCM. We were able to successfully implement this strategy
in an anatomically precise way as evidenced by our gene expression data. Clear differences in
the expression of genes that are specifically associated with serotonergic and/or noradrenergic
transmission were detected. For example, consistent with previous reports we detected
expression of TH and NET in the noradrenergic LC but not in the serotonergic DR and MR
(Eymin et al., 1995). On the other hand, TPH2 (Patel et al., 2004) and SERT (Austin et al.,
1994) mRNAs are primarily expressed in the raphe nuclei, which was also confirmed in our
study. Furthermore, PNMT, the synthetic enzyme for epinephrine, is not expressed in
serotonergic or noradrenergic neurons (Carton et al., 1989) and, as expected, its mRNA was
not detected in any of the nuclei that we examined.
In addition to these unique mRNAs, serotonergic and noradrenergic transmitter systems also
share several enzymes, including MAO-A and MAO-B (Jahng et al., 1997). However, their
relative content differs between the two systems. Compared to MAO-B, MAO-A mRNA is
more abundant in the human LC, while the converse is true within DR and MR (Saura et al.,
1996; Ordway et al., 1999). These findings were also confirmed by our microarray (Fig. 3) and
qPCR (Fig. 4) analyses.
Taken together these data validate ISH-guided LCM method and demonstrate the feasibility
of combining it with gene expression profiling and qPCR validation. Its increased anatomical
resolution leads to more precise sampling, which in turn enriches expression of specific
mRNAs and improves sensitivity and dynamic range of microarray-based gene expression
profiling. We also present preliminary evidence that this method can be applied to identification
of uniquely enriched transcripts within the three monoaminergic regions included in this study
(Table 5). Though these data are preliminary and will require additional confirmation, they are
consistent with previous reports that documented similar expression patterns for VIP (Hill et
al., 1994;Hill et al., 2003), RGS3 (Gold et al., 1997), and RGS4 (Gold et al., 1997) in the rodent
brain.
As noradrenergic and serotonergic neurotransmission is implicated in the etiology of major
depression (Maas et al., 1987; Leonard, 2000) and bipolar disorder (Swann et al., 1999), use
of this ISH-guided LCM approach has the potential to uncover novel gene expression
alterations in these illnesses in key monoaminergic brain regions. Having validated ISH-guided
LCM on brain regions with clear anatomical borders and known neurochemical differences,
we also plan to apply this method to gene expression studies of human postmortem brain areas
that are less defined by anatomical landmarks but more by their neurochemical content (such
as neuropeptides).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Brain sections containing noradrenergic and serotonergic brainstem nuclei. A — coronal
brainstem section stained with luxol fast blue combined with cresyl violet. Dashed square area
in panel A is shown at higher magnification in B. It illustrates the region containing locus
coeruleus, as identified by the dark-colored melanin-containing cells. Adjacent sections to the
one shown in A were processed for norepinephrine transporter (C) and serotonin transporter
(D) in situ hybridizations. Panels E and F display sections that were adjacent to those in C and
D, respectively, from which locus coeruleus (bilaterally; E) and dorsal and median raphe (F)
have been removed by laser capture microdissection. In F note that the microdissected dorsal
aspect contained the dorsal raphe nucleus, whereas the removed ventral area represented the
median raphe nucleus. All scale bars - 1 mm. Abbreviations: 4V -fourth ventricle, ctg - central
tegmental tract, DR — dorsal raphe nucleus, LC - locus coeruleus, mlf - medial longitudinal
fasciculus, MR — median raphe nucleus, PnO -pontine reticular nucleus, oral part, scp -
superior cerebellar peduncle.
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Figure 2.
RNA electropherograms from LCM-dissected samples. Representative electropherograms
from LC, DR, and MR are shown (numbers refer to subject identifiers). Locations of marker,
18S, and 28S peaks are shown with arrows. Such traces were used to calculate area under the
curve for different portions of the electropherogram as part of RNA quality assessment (see
text for details).
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Figure 3.
Expression of specific noradrenergic and serotonergic mRNAs. Comparisons of gene
expression intensities were sorted into four classes: synthetic enzymes (A), transporters (B),
and degradative enzymes (C). * - p< 0.05 vs. LC, # - p < 0.05 vs. MR (one-way ANOVA with
Bonferroni’s multiple comparison post-hoc tests). Abbreviations: COMT — catechol-O-
methyl transferase, DBH — dopamine β-hydroxylase, DDC — aromatic amino acid
decarboxylase, MAO-A — monoamine oxidase A, MAO-B — monoamine oxidase B, NET
— norepinephrine transporter, n. d. — not detected, PNMT — phenylethanolamine-N-methyl
transferase, SERT — serotonin transporter, TH — tyrosine hydroxylase, TPH2 — tryptophan
hydroxylase 2, VMAT2 — vesicular monoamine transporter 2.
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Figure 4.
Comparison of differences in gene expression as detected by microarrays and qPCR. For each
gene fold changes were calculated relative to mean expression value (intensity measure for
microarrays, and Ct for qPCR) in LC. In the case of MAOA and TPH2, qPCR was not
performed in LC. Data for DR and MR are presented for these transcripts; differences in gene
expression were calculated relative to DR. Note the difference in the scale of y-axes between
microarrays and qPCR plots, which is due to the larger magnitude of changes detected by
qPCR. * - p < 0.05 as compared to LC; # - p < 0.05 vs. MR.
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Figure 5.
Correlations between qPCR and microarray results. Relationship between qPCR cycle
thresholds and log2 array intensities is depicted for 5 monoamine genes that are expressed in
all three nuclei. Linear regression analysis was performed and deviation from zero was
statistically evaluated. Goodness of linear regression fit (R2) were 0.49, 0.16, 0.29,0.79, 0.89
for DCC, COMT, MAOA, MAOB, and SERT, respectively . Correlations for all 5 genes were
statistically significant (p<0.05).
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